메뉴 건너뛰기




Volumn 118, Issue 4-5, 2010, Pages 273-276

Clinical, pathological, proliferative and molecular responses associated with neoadjuvant aromatase inhibitor treatment in breast cancer

Author keywords

Aromatase inhibitors; Breast cancer; Response

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; CCNB1 PROTEIN; CKS2 PROTEIN; CYCLIN DEPENDENT KINASE 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; KI 67 ANTIGEN; LETROZOLE; PROTEIN; TAMOXIFEN; UNCLASSIFIED DRUG; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

EID: 77950353241     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.10.005     Document Type: Conference Paper
Times cited : (28)

References (26)
  • 3
    • 0242541296 scopus 로고    scopus 로고
    • Neoadjuvant tamoxifen and aromatase inhibitors: Comparisons and clinical outcomes
    • J.M. Dixon, J. Jackson, L. Renshaw, W.R. Miller, Neoadjuvant tamoxifen and aromatase inhibitors: comparisons and clinical outcomes, J. Steroid. Biochem. Mol. Biol. 86 (3-5) (2003) 295-299.
    • (2003) J. Steroid. Biochem. Mol. Biol. , vol.86 , Issue.3-5 , pp. 295-299
    • Dixon, J.M.1    Jackson, J.2    Renshaw, L.3    Miller, W.R.4
  • 7
    • 24644490871 scopus 로고    scopus 로고
    • Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: The Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial
    • IMPACT Trialists Group
    • I.E. Smith, M. Dowsett, S.R. Ebbs, J.M. Dixon, A. Skene, J.U. Blohmer, S.E. Ashley, S. Francis, I. Boeddinghaus, G. Walsh, IMPACT Trialists Group, Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial, J. Clin. Oncol. 23 (22) (2005) 5108-5116.
    • (2005) J. Clin. Oncol. , vol.23 , Issue.22 , pp. 5108-5116
    • Smith, I.E.1    Dowsett, M.2    Ebbs, S.R.3    Dixon, J.M.4    Skene, A.5    Blohmer, J.U.6    Ashley, S.E.7    Francis, S.8    Boeddinghaus, I.9    Walsh, G.10
  • 8
    • 0033008206 scopus 로고    scopus 로고
    • Lessons from the use of aromatase inhibitors in the neoadjuvant setting
    • J.M. Dixon, C.D.B. Love, L. Renshaw, et al., Lessons from the use of aromatase inhibitors in the neoadjuvant setting, Endocr. Relat. Cancer 6 (1999) 227-230.
    • (1999) Endocr. Relat. Cancer , vol.6 , pp. 227-230
    • Dixon, J.M.1    Love, C.D.B.2    Renshaw, L.3
  • 9
    • 1542294791 scopus 로고    scopus 로고
    • Pathology of breast cancer following neoadjuvant therapy
    • W.R. Miller, J.N. Ingle (Eds.), Marcel Dekker, New York, USA
    • H. Sasano, T. Suzuki, T. Moriya, Pathology of breast cancer following neoadjuvant therapy, in: W.R. Miller, J.N. Ingle (Eds.), Endocrine Therapy in Breast Cancer, Marcel Dekker, New York, USA, 2002, pp. 213-222.
    • (2002) Endocrine Therapy in Breast Cancer , pp. 213-222
    • Sasano, H.1    Suzuki, T.2    Moriya, T.3
  • 10
    • 0345314101 scopus 로고    scopus 로고
    • Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen
    • W.R. Miller, J.M. Dixon, L. Macfarlane, et al., Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen, Eur. J. Cancer 39 (4) (2002) 462-468.
    • (2002) Eur. J. Cancer , vol.39 , Issue.4 , pp. 462-468
    • Miller, W.R.1    Dixon, J.M.2    MacFarlane, L.3
  • 11
    • 0037194407 scopus 로고    scopus 로고
    • Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer
    • T.J. Anderson, J.M. Dixon, M. Stuart, et al., Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer, Br. J. Cancer 87 (2002) 334-338.
    • (2002) Br. J. Cancer , vol.87 , pp. 334-338
    • Anderson, T.J.1    Dixon, J.M.2    Stuart, M.3
  • 12
    • 0035717497 scopus 로고    scopus 로고
    • Biological and clinical effects of aromatase inhibitors in neoadjuvant therapy
    • W.R. Miller, J.M. Dixon, D.A. Cameron, T.J. Anderson, Biological and clinical effects of aromatase inhibitors in neoadjuvant therapy, J. Steroid Biochem.Mol. Biol. 79 (1-5) (2001) 103-107.
    • (2001) J. Steroid Biochem.Mol. Biol. , vol.79 , Issue.1-5 , pp. 103-107
    • Miller, W.R.1    Dixon, J.M.2    Cameron, D.A.3    Anderson, T.J.4
  • 13
    • 33645735920 scopus 로고    scopus 로고
    • Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole
    • W.R. Miller, S. White, J.M. Dixon, J. Murray, L. Renshaw, T.J. Anderson, Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole, Br. J. Cancer 94 (2006) 1051-1056.
    • (2006) Br. J. Cancer , vol.94 , pp. 1051-1056
    • Miller, W.R.1    White, S.2    Dixon, J.M.3    Murray, J.4    Renshaw, L.5    Anderson, T.J.6
  • 14
    • 19944429855 scopus 로고    scopus 로고
    • IMPACT Trialists: Short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival
    • M. Dowsett, I.E. Smith, S.R. Ebbs, J.M. Dixon, A. Skene, C. Griffith, I. Boeddinghaus, J. Salter, S. Detre, M. Hills, S. Ashley, S. Francis, G. Walsh, IMPACT Trialists: short-term changes in Ki-67 during neoadjuvant treatment of primary breast cancer with anastrozole or tamoxifen alone or combined correlate with recurrence-free survival, Clin. Cancer Res. 11 (2 Pt 2) (2005) 951s-958s.
    • (2005) Clin. Cancer Res. , vol.11 , Issue.2 PART 2
    • Dowsett, M.1    Smith, I.E.2    Ebbs, S.R.3    Dixon, J.M.4    Skene, A.5    Griffith, C.6    Boeddinghaus, I.7    Salter, J.8    Detre, S.9    Hills, M.10    Ashley, S.11    Francis, S.12    Walsh, G.13
  • 15
    • 23744448408 scopus 로고    scopus 로고
    • Clinical and biomarker endpoint analysis in neoadjuvant endocrine therapy trials
    • Y. Tao, A. Klause, A. Vickers, K. Bae, M. Ellis, Clinical and biomarker endpoint analysis in neoadjuvant endocrine therapy trials, J. Steroid Biochem. Mol. Biol. 95 (1-5) (2005) 91-95.
    • (2005) J. Steroid Biochem. Mol. Biol. , vol.95 , Issue.1-5 , pp. 91-95
    • Tao, Y.1    Klause, A.2    Vickers, A.3    Bae, K.4    Ellis, M.5
  • 16
    • 0035576786 scopus 로고    scopus 로고
    • HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer
    • M. Dowsett, C. Harper-Wynne, I. Boeddinghaus, J. Salter, M. Hills, M. Dixon, S. Ebbs, G. Gui, N. Sacks, I. Smith, HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer, Cancer Res. 61 (23) (2001) 8452-8458.
    • (2001) Cancer Res. , vol.61 , Issue.23 , pp. 8452-8458
    • Dowsett, M.1    Harper-Wynne, C.2    Boeddinghaus, I.3    Salter, J.4    Hills, M.5    Dixon, M.6    Ebbs, S.7    Gui, G.8    Sacks, N.9    Smith, I.10
  • 17
    • 9644262523 scopus 로고    scopus 로고
    • Anastrozole demonstrates clinical and biological effectiveness in oestrogen receptor-positive breast cancers, irrespective of the erbB2 status
    • J.M. Dixon, J. Jackson, M. Hills, L. Renshaw, D.A. Cameron, T.J. Anderson, W.R. Miller, M. Dowsett, Anastrozole demonstrates clinical and biological effectiveness in oestrogen receptor-positive breast cancers, irrespective of the erbB2 status, Eur. J. Cancer 40 (18) (2004) 2742-2747.
    • (2004) Eur. J. Cancer , vol.40 , Issue.18 , pp. 2742-2747
    • Dixon, J.M.1    Jackson, J.2    Hills, M.3    Renshaw, L.4    Cameron, D.A.5    Anderson, T.J.6    Miller, W.R.7    Dowsett, M.8
  • 18
    • 25844433766 scopus 로고    scopus 로고
    • Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: The Edinburgh experience
    • W.R. Miller, T.J. Anderson, S. White, D. Evans, A. Krause, J.M. Dixon, Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: the Edinburgh experience, Endocr. Relat. Cancer 12 (Suppl 1) (2005) S119-123.
    • (2005) Endocr. Relat. Cancer , vol.12 , Issue.SUPPL. 1
    • Miller, W.R.1    Anderson, T.J.2    White, S.3    Evans, D.4    Krause, A.5    Dixon, J.M.6
  • 20
    • 0035884620 scopus 로고    scopus 로고
    • Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB- 1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: Evidence from a phase III randomized trial
    • M.J. Ellis, A. Coop, B. Singh, L. Mauriac, A. Llombert-Cussac, F. Janicke, W.R. Miller, D.B. Evans, D. Dugan, C. Brady, E. Quebe-Fehling, M. Borgs, Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB- 1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial, J. Clin. Oncol. 19 (No 18) (2001) 3808-3816.
    • (2001) J. Clin. Oncol. , vol.19 , Issue.18 , pp. 3808-3816
    • Ellis, M.J.1    Coop, A.2    Singh, B.3    Mauriac, L.4    Llombert-Cussac, A.5    Janicke, F.6    Miller, W.R.7    Evans, D.B.8    Dugan, D.9    Brady, C.10    Quebe-Fehling, E.11    Borgs, M.12
  • 24
    • 38749100194 scopus 로고    scopus 로고
    • Predicting response and resistance to endocrine therapy: Profiling patients on aromatase inhibitors
    • W.R. Miller, A. Larionov, T.J. Anderson, J.R. Walker, A. Krause, D.B. Evans, J.M. Dixon, Predicting response and resistance to endocrine therapy: profiling patients on aromatase inhibitors, Cancer 112 (S3) (2007) 689-694.
    • (2007) Cancer , vol.112 S3 , pp. 689-694
    • Miller, W.R.1    Larionov, A.2    Anderson, T.J.3    Walker, J.R.4    Krause, A.5    Evans, D.B.6    Dixon, J.M.7
  • 26
    • 60749126579 scopus 로고    scopus 로고
    • Identification and mechanisms of endocrine resistance
    • W.R. Miller, Identification and mechanisms of endocrine resistance, Breast Cancer Res. 10 (Suppl 4) (2008) S19.
    • (2008) Breast Cancer Res. , vol.10 , Issue.SUPPL. 4
    • Miller, W.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.